Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
What's new? Regulatory T cells (Treg) appear to contribute to poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC), suggesting that Treg cells are key therapeutic targets.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
International journal of cancer
Year: 2013, Jahrgang: 133, Heft: 1, Pages: 98-107 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.27990 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ijc.27990 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/ijc.27990 
|
| Verfasserangaben: | Ivan Shevchenko, Svetlana Karakhanova, Sabine Soltek, Julia Link, Jagadeesh Bayry, Jens Werner, Viktor Umansky and Alexandr V. Bazhin |